Obstructive Sleep Apnea News and Research

RSS

Obstructive sleep apnea (OSA) is a major heath problem. In the United States, at least 17 million people have moderate to severe OSA, which is characterized by heavy snoring, airway blockage and frequent awakenings during sleep.

One year of CPAP therapy restores white matter, improves cognition and mood

A neuroimaging study is the first to show that white matter damage caused by severe obstructive sleep apnea can be reversed by continuous positive airway pressure therapy.

9 Sep 2014

Sleeping 7 to 8 hours per night associated with lowest risk of work absence

New research suggests that sleeping 7 to 8 hours per night is associated with the lowest risk of absence from work due to sickness.

4 Sep 2014

UH Case Medical Center offers new FDA-approved treatment for obstructive sleep apnea

University Hospitals Case Medical Center is the first in Ohio and among the first in the United States to begin offering a new FDA-approved treatment for obstructive sleep apnea (OSA).

16 Aug 2014

Severe obstructive sleep apnea associated with elevated blood pressure despite medication use

A new study shows a strong association between severe, untreated obstructive sleep apnea and the risk of elevated blood pressure despite the use of high blood pressure medications.

15 Aug 2014

Weight loss most important factor for improving cardiovascular health in obese OSA patients

Obesity and obstructive sleep apnea (OSA) tend to co-exist and are associated with a variety of cardiovascular risk factors, including inflammation, insulin resistance, abnormal cholesterol, and high blood pressure. While effective therapies are available for OSA, researchers are still unclear about what interventions are most effective in reducing the burden of risk factors for cardiovascular disease associated with OSA in obese patients.

13 Jun 2014

USITC rules out patent claims on Apex's CPAP-complimentary mask

Apex Medical Corporation a leading player in the Respiratory Therapy and Pressure Area Care sectors, announced that it has successfully obtained an initial advisory opinion from the United States International Trade Commission (USITC) that its continuous positive airway pressure (CPAP)-complimentary mask product is free from patent claims previously asserted by its Australia-based competitor, ResMed.

6 Jun 2014

Study demonstrates link between obstructive sleep apnea and development of diabetes

In the largest study to date of the relationship between sleep apnea and diabetes, a new study of more than 8,500 Canadian patients has demonstrated a link between obstructive sleep apnea (OSA) and the development of diabetes, confirming earlier evidence of such a relationship from smaller studies with shorter follow-up periods.

6 Jun 2014

Hypertensive pregnant women who snore may have unrecognized obstructive sleep apnea

1 in 2 hypertensive pregnant women who habitually snore may have unrecognized obstructive sleep apnea, a sleeping disorder that can reduce blood oxygen levels during the night and that has been linked to serious health conditions, new University of Michigan-led research shows.

3 Jun 2014

Compliance with CPAP therapy may help prevent cardiovascular complications

A new study suggests that continuous positive airway pressure (CPAP) therapy rapidly improves blood pressure and arterial tone in adults with obstructive sleep apnea (OSA).

3 Jun 2014

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

Jazz Pharmaceuticals plc today presented data from the Phase 2b study evaluating JZP-110 (formerly known as ADX-N05) as a potential new treatment for the symptoms of excessive daytime sleepiness (EDS) in adults with narcolepsy.

3 Jun 2014

Actavis signs deal with Cephalon to settle patent litigation related to Nuvigil tablets

Actavis plc today announced that it has entered into an agreement with Cephalon, Inc. to settle all outstanding patent litigation related to Actavis' generic version of Nuvigil® (armodafinil tablets, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg).

31 May 2014

Study explores role of family factors in CPAP adherence in sleep apnea patients

A new study suggests that people with obstructive sleep apnea (OSA) who are single or have unsupportive family relationships may be less likely to adhere to continuous positive airway pressure (CPAP) therapy.

30 May 2014

Home testing and CPAP therapy initiation for OSA may reduce costs without sacrificing clinical outcomes

Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes, researchers have shown in a new study presented at the American Thoracic Society International Conference.

20 May 2014

Umbian announces outcome of new study for U-Sleep automated messaging system

Umbian Inc., a ResMed (NYSE: RMD) company, and leading provider of cloud-based healthcare compliance solutions, today announced the outcome of a new study that shows significant, measurable efficiency gains when using the automated messaging capabilities of its U-Sleep compliance management solution.

19 May 2014

Inspire Medical Systems completes $40 million Series E financing

Inspire Medical Systems, Inc. announced today that it has completed a Series E financing of $40 million. The financing round was strategically timed to coincide with the commercial launch of the Inspire Upper Airway Stimulation (UAS) therapy in the United States.

15 May 2014

Pregnant women with obstructive sleep apnea more likely to die in hospital

Pregnant women with obstructive sleep apnea are more than five times as likely to die in the hospital than those without the sleep disorder, a comprehensive national study by the University of South Florida researchers found.

5 May 2014

Study shows obstructive sleep apnea is associated with increased risk of stroke, cancer and death

A new study shows that moderate to severe obstructive sleep apnea is independently associated with an increased risk of stroke, cancer and death.

15 Apr 2014

Researchers develop new screening tool to help diagnose obstructive sleep apnea in children

Clinical investigators at the Children's Hospital of Eastern Ontario (CHEO) have developed a new screening tool to help diagnose obstructive sleep apnea in children. Their findings are published in Pediatric Pulmonology.

2 Apr 2014

Bariatric surgery reduces uterine cancer risk by 71%

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center report that bariatric surgery resulting in dramatic weight loss in formerly severely obese women reduces the risk of endometrial (uterine) cancer by 71 percent and as much as 81 percent if normal weight is maintained after surgery.

24 Mar 2014

WTC first responders at higher risk for obstructive sleep apnea, PTSD

Icahn School of Medicine at Mount Sinai researchers have linked high levels of exposure to inhaled particulate matter by first responders at Ground Zero to the risk of obstructed sleep apnea and post-traumatic stress disorder (PTSD), both conditions that may impact cardiovascular health.

21 Mar 2014

Obstructive Sleep Apnea News and Research

Further Reading

One year of CPAP therapy restores white matter, improves cognition and mood

Sleeping 7 to 8 hours per night associated with lowest risk of work absence

UH Case Medical Center offers new FDA-approved treatment for obstructive sleep apnea

Severe obstructive sleep apnea associated with elevated blood pressure despite medication use

Weight loss most important factor for improving cardiovascular health in obese OSA patients

USITC rules out patent claims on Apex's CPAP-complimentary mask

Study demonstrates link between obstructive sleep apnea and development of diabetes

Hypertensive pregnant women who snore may have unrecognized obstructive sleep apnea

Compliance with CPAP therapy may help prevent cardiovascular complications

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

Actavis signs deal with Cephalon to settle patent litigation related to Nuvigil tablets

Study explores role of family factors in CPAP adherence in sleep apnea patients

Home testing and CPAP therapy initiation for OSA may reduce costs without sacrificing clinical outcomes

Umbian announces outcome of new study for U-Sleep automated messaging system

Inspire Medical Systems completes $40 million Series E financing

Pregnant women with obstructive sleep apnea more likely to die in hospital

Study shows obstructive sleep apnea is associated with increased risk of stroke, cancer and death

Researchers develop new screening tool to help diagnose obstructive sleep apnea in children

Bariatric surgery reduces uterine cancer risk by 71%

WTC first responders at higher risk for obstructive sleep apnea, PTSD

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News